Compare HDSN & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HDSN | CDXS |
|---|---|---|
| Founded | 1991 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.0M | 256.3M |
| IPO Year | 1996 | 2008 |
| Metric | HDSN | CDXS |
|---|---|---|
| Price | $6.22 | $2.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 577.5K | ★ 872.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.82 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $237,118,000.00 | $138,590,000.00 |
| Revenue This Year | $2.51 | $7.73 |
| Revenue Next Year | $2.38 | $14.24 |
| P/E Ratio | $629.50 | ★ N/A |
| Revenue Growth | N/A | ★ 32.30 |
| 52 Week Low | $4.64 | $0.96 |
| 52 Week High | $10.52 | $3.87 |
| Indicator | HDSN | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 58.74 | 43.33 |
| Support Level | $5.55 | $1.57 |
| Resistance Level | $6.51 | $2.72 |
| Average True Range (ATR) | 0.28 | 0.16 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 70.39 | 22.88 |
Hudson Technologies Inc is a refrigerant services company providing solutions to recurring challenges within the refrigeration industry. The company delivers environmentally sustainable offerings, covering the sale of refrigerant gases, recovery, reclamation, and reuse, as well as improving equipment performance through energy efficiency services, emergency air conditioning and refrigeration system repairs, refrigerant disposal, and carbon credit trading. It operates through one reportable segment. Its products and services are used in commercial air conditioning, industrial processing, and refrigeration systems, and include refrigerant and industrial gas sales, refrigerant management services (mainly reclamation of refrigerants), and RefrigerantSide services performed at customer sites.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.